Home » Johnson & Johnson MedTech advances surgical robotics with Nvidia AI, plans 2026 launch The Monarch platform for urology leveraging AI-driven simulation with Nvidia accelerated compute. [Image courtesy of Johnson & Johnson MedTech] Johnson & Johnson MedTech (NYSE: JNJ) today announced new advances in surgical robotic technology with physical AI capabilities. The medtech giant

Cybersecurity firm Rapid7 warns that organisations worldwide are entering a period of escalating cyber risk, driven by advances in artificial intelligence, quantum computing, and geopolitical tension. Compiled by Senior Threat Intelligence Researcher Jeremy Makowski, the report outlines how emerging technologies are fuelling a new era of cyber warfare - one where AI serves as both

ORIGINAL RESEARCH article Front. Oncol. Sec. Cancer Imaging and Image-directed Interventions This article is part of the Research Topic Radiomics and AI-Driven Deep Learning for Cancer Diagnosis and Treatment View all 18 articles 1 Department of Radiology, Second Affiliated Hospital of Chongqing Medical University, Chongqing, China 2 GE Healthcare, Advanced analytics team, Shanghai, China 3

OpenAI has completed a major reorganisation and, in the same breath, signed a new definitive partnership agreement with Microsoft. Starting with OpenAI’s reorganisation, the aim is to solidify the nonprofit’s control over the for-profit business and establish the newly named OpenAI Foundation as a global philanthropic powerhouse, holding equity in the commercial arm valued at

Oct 28, 2025 · 4 min read REDWOOD CITY, Calif. — October 28, 2025 — Today, the Chan Zuckerberg Initiative (CZI) and NVIDIA announced an expanded collaboration to accelerate life science research by driving development and adoption of virtual cell models through tools, data, models, and benchmarks delivered through CZI’s virtual cells platform (VCP). Core

At its “Research to Reality” media event on Thursday, Google showcased DeepSomatic, an AI tool that accurately identifies cancer-causing genetic mutations, outperforming current methods according to a study published in Nature Biotechnology on October 16.”DeepSomatic is an AI tool that helps scientists find genetic variants in cancer cells that could enable personalized treatment,” said Yossi

According to experts, inferencing will account for the lion’s share of AI calculations. Qualcomm is seizing the opportunity to offer an alternative to the established players in the data center. A ‘rich software stack’ should entice customers to switch. The rack-scale systems promise high performance and efficiency, with memory advantages to handle the largest AI

Author 95% of AI pilots fail, according to an MIT report. It’s not because the technology doesn’t work, but because enterprises apply too narrow of a lens to their transformation. They’ve overlooked key components: processes, data, adjacent technologies and the people around them. This point came into sharp focus at the HFS roundtable in September